Angiotensin converting enzyme genotype and chronic allograft nephropathy in protocol biopsies

Journal of the American Society of Nephrology

Volumn 15, Issue 8, 2004, Pages 2229-2236

  Hueso, Miguel ^a,b   Alía, Pedro ^a   Moreso, Francesc ^a   Beltrán Sastre, Violeta ^b   Riera, Luis ^a   González, Carlota ^a   Navarro, Miguel Ángel ^a   Grinyó, Josep Maria ^a   Navarro, Estanis ^b   Serón, Daniel ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b HOSPITAL DURAN I REYNALS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN;

ADULT; AGED; ARTICLE; DISEASE ASSOCIATION; ENZYME ANALYSIS; FEMALE; GENOTYPE; GENOTYPE DD; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; INCIDENCE; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RNA ANALYSIS;

EID: 3543134795     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000135054.54810.75     Document Type: Article

References (33)

1. Serón D, Moreso P, Bover J, Condom E, Gil-Vernet S, Cañas C, Fulladosa X, Torras J, Carrera M, Grinyó JM, Aisina J: Early protocol renal allograft biopsies and graft outcome. Kidney Int 51: 310-316, 1997
2. Almond PS, Matas A, Gillingham K, Dunn DL, Payne WD, Gores P, Gruessner R, Najarian JS: Risk factors for chronic rejection in renal allograft recipients. Transplantation 55: 752-757, 1993
3. Turner D, Grant S, Yonan N, Sheldon S, Dyer P, Sinnott P, Hutchinson I: Cytokine gene polymorphism and heart transplant rejection. Transplantation 64: 776-779, 1997
4. Awad M, El-Gamel A, Hasleton P, Turner D, Sinnott P, Hutchinson I: Genotypic variation in the transforming growth factor-β1 gene. Transplantation 66: 1014-1020, 1998
5. Aros C, Remuzzi G: The renin-angiotensin system in progression, remission and regression of chronic nephropathies. J Hyperten 20[Suppl 3]: S45-S53, 2002
6. Taal MW, Brenner B: Renoprotective benefits of RAS inhibition: From ACEI to angiotensin II antagonists. Kidney Int 57: 1803-1817, 2000
7. Navis G, de Jong PE, De Zeeuw D: I/D polymorphism of the angiotensin converting enzyme gene: A clue to the heterogeneity of renal disease and in the renal response to therapy? Nephrol Dial Transplant 12: 1097-1100, 1997
8. Jacobsen P, Tarnow L, Cartensen B, Hovind P, Poirer O, Parving H: Genetic variation in the renin-angiotensin system and progression of diabetic nephropathy. J Am Soc Nephrol 14: 2843-2850, 2003
9. Harden PN, Geddes C, Rowe PA, McIlroy JH, Boulton-Jones M, Rodger RS, Junor BJ, Briggs JD, Connell JM, Jardine AG: Polymorphisms in the angiotensin-converting enzyme and progression of IgA nephropathy. Lancet 345: 1540-1542, 1995
10. Baboolal K, Ravine D, Daniels J, Williams N, Holamans P, Coles GA, Williams JD: Association of the angiotensin I converting enzyme gene deletion polymorphism with early onset of ESRF in PKD1 adult polycystic kidney disease. Kidney Int 52: 607-613, 1997
11. Abdi R, Huong T, Zee R, Brenner B, Milford E: Angiotensin gene polymorphism as A determinant of posttransplantation renal dysfunction and hypertension. Transplantation 72: 726-729, 2001
12. Broekroelofs J, Stegeman CA, Navis G, Tegzess AM, Zeeuw D, De Jong P: Risk factors for long-term renal survival after renal transplantation: A role for Angiotensin-converting enzyme (insertion/deletion) polymorphism? J Am Soc Nephrol 9: 2075-2081, 1998
13. Barocci S, Ginevri F, Valente U, Torre F, Gusmano R, Nocera A: Correlation between angiotensin-converting enzyme gene insertion/deletion polymorphism and kidney graft long-term outcome in pediatric recipients. Transplantation 67: 534-538, 1999
14. Beige J, Scherer S, Weber A, Engeli S, Offermann G, Opelz G, Distler A, Sharma AM: Angiotensin-converting enzyme genotype and renal allograft survival. J Am Soc Nephrol 8: 1319-1323, 1997
15. Beige J, Offermann G, Distler A, Sharma AM: Angiotensin-converting enzyme insertion/deletion genotype and long term renal allograft survival. Nephrol Dial Transplant 13: 735-738, 1998
16. Nankivell BJ, Borrows RJ, Fung CLS, O'Connell PJ, Allen RDM, Chapman J: The natural history of chronic allograft nephropathy. N Engl J Med 349: 2326-2333, 2003
17. Moreso F, Lopez M, Vallejos A, Giordani C, Riera L, Fulladosa X, Hueso M, Alsina J, Grinyó JM, Serón D: Serial protocol biopsies to quantify the progression of chronic transplant nephropathy in stable renal allografts. Am J Transplant 1: 82-88, 2000
18. Serón D, Moreso F, Ramon JM, Hueso M, Condom E, Fulladosa X, Bover J, Gil-Vernet S, Castelao AM, Alsina J, Grinyó JM: Protocol renal allograft biopsies and the design of clinical trials aimed to prevent or treat chronic allograft nephropathy. Transplantation 69: 1849-1855, 2000
19. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16: 31-41, 1976
20. Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, Croker BP, Demetris AJ, Drachenberg CB, Fogo AB, Furness P, Gaber LW, Gibson IW, Glotz D, Goldberg JC, Grande J, Halloran PF, Hansen HE, Hartley B, Hayry PJ, Hill CM, Huffman EO, Hunsicker LG, Lindblad AS, Yamaguchi Y, et al: The Banff 97 working classification of renal allograft pathology. Kidney Int 55: 713-723, 1999
21. Sanbrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual, 2nd Ed., Cold Spring Harbour, Cold Spring Harbour Laboratory Press, 1989
22. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86: 1343-1346, 1990
23. Hueso M, Beltran V, Moreso F, Ciriero E, Fulladosa X, Grinyó JM, Serón D, Navarro E: Splicing alterations in human renal allografts: Detection of a new splice variant of protein kinase Par1/Emk1 whose expression is associated with an increase of inflammation in protocol biopsies of transplanted patients. Biochim Biophys Acta 1689: 58-65, 2004
24. Von Schnakenburg C, Strehlau J, Ehrich J, Melk A: Quantitative gene expression of TGF-β1, IL-10, TNF-α Fas ligand in renal cortex and medulla. Nephrol Dial Transplant 17: 573-579, 2002
25. Melk A, Henne T, Kollmar T, Strehlau J, Latta K, Offner G, Jhangri G, Ehrich JHH, Von Schnakenburg C: Cytokine single nucleotide polymorphisms and intrarenal gene expression in chronic allograft nephropathy in children. Kidney Int 64: 314-320, 2003
26. Serón D, Moreso F, Fulladosa X, Hueso M, Carrera M, Grinyó JM: Reliability of chronic allograft nephropathy diagnosis in sequential protocol biopsies. Kidney Int 61: 727-733, 2002
27. Schmidt S, Strojek K, Grzeszczak W, Bergis K, Ritz E, Diabetic Nephropathy Study Group: Excess of DD homozygotes in haemodialysed patients with type II diabetes. Nephrol Dial Transplant 12: 427-429, 1997
28. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F: Evidence, from combined segregation and linkage analysis, that a variant of angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 51: 197-205, 1992
29. Mizuiri S, Hemmi H, Kumanomidou H, Iwamoto M, Miyagi M, Sakai K, Aikawa A, Ohara T, Yamada K, Shimatake H, Hasegawa A: Angiotensin-converting enzyme (ACE) I/D genotype and renal ACE gene expression. Kidney Int 60: 1124-1130, 2001
30. Costerousse O, Allegrini J, Lopez M, Alhec-Gelas F: Angiotensin I converting enzyme in human circulating mononuclear cells: Genetic polymorphism of expression in T-lymphocytes. Biochem J 290:33-40, 1993
31. Lagaaij E, Cramer-Knijnenburg G, Van Kemenade F, Van Es L, Brujin J, Van Krieken J: Endothelial cell chimerism after renal transplantation and vascular rejection. Lancet 357: 33-37, 2001
32. Poulsom R, Forbes SJ, Hodivala-Dilke K, Ryan E, Wyles S, Navaratnarasah S, Jeffery R, Hunt T, Alison M, Cook T, Pusey C, Wright NA: Bone marrow contributes to renal turnover and regeneration. J Pathol 195: 229-235, 2001
33. Cornacchia F, Fornoni A, Plati AR, Thomas A, Wang Y, Inverardi L, Striker LJ, Striker GE: Glomerulosclerosis is transmitted by bone marrow-derived mesangial cell progenitors. J Clin Invest 108: 1649-1656, 2001